Log in to save to my catalogue

Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-con...

Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-con...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2321682160

Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial

About this item

Full title

Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-12, Vol.14 (12), p.e0225748

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Ketorolac has been associated with a lower risk of recurrence in retrospective studies, especially in patients with positive inflammatory markers. It is still unknown whether a single dose of pre-incisional ketorolac can prolong recurrence-free survival.
The KBC trial is a multicenter, placebo-controlled, randomized phase III trial in high-risk...

Alternative Titles

Full title

Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2321682160

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2321682160

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0225748

How to access this item